Back
Avalo Therapeutics Stock Price Chart
7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Sell
25
AVTX
Avalo Therapeutics
Last Price:
$4.90
Seasonality Move:
-8.45%
7 Day Trial
ALL ACCESS PASS
$
7
ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AVTX is experiencing slight buying pressure.
Avalo Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.88 | Buy |
| 20-day SMA: | 4.8 | Buy |
| 50-day SMA: | 4.46 | Buy |
| 200-day SMA: | 7.67 | Sell |
| 8-day EMA: | 4.87 | Buy |
| 20-day EMA: | 4.75 | Buy |
| 50-day EMA: | 4.84 | Buy |
| 200-day EMA: | 13.58 | Sell |
Avalo Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 56.37 | Buy |
| Chaikin Money Flow: | 15821 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.49 - 4.93) | Buy |
| Bollinger Bands (100): | (4.12 - 7.12) | Sell |
Avalo Therapeutics Technical Analysis
| Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | Jul | |||||||||
| 25 | 26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Avalo Therapeutics Stock
Is Avalo Therapeutics Stock a Buy?
-
Avalo Therapeutics share price is 4.95 while AVTX 8-day simple moving average is 4.88, which is a Buy signal.
-
The stock price of AVTX is 4.95 while Avalo Therapeutics 20-day SMA is 4.80, which makes it a Buy.
-
Avalo Therapeutics 50-day simple moving average is 4.46 while AVTX share price is 4.95, making it a Buy technically.
-
AVTX stock price is 4.95 and Avalo Therapeutics 200-day simple moving average is 7.67, creating a Sell signal.
AVTX Technical Analysis vs Fundamental Analysis
Sell
25
Avalo Therapeutics (AVTX)
is a Sell
Is Avalo Therapeutics a Buy or a Sell?
-
Avalo Therapeutics stock is rated a SellThe current Avalo Therapeutics [AVTX] share price is $4.95. The Score for AVTX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Avalo Therapeutics Stock Info
Market Cap:
53.6M
Price in USD:
4.95
Share Volume:
52.7K
Avalo Therapeutics 52-Week Range
52-Week High:
16.00
52-Week Low:
3.39
Sell
25
Avalo Therapeutics (AVTX)
is a Sell
Avalo Therapeutics Share Price Forecast
-
What is the Avalo Therapeutics stock price today?The Avalo Therapeutics stock price is 4.95 USD today.
-
Will AVTX stock go up or go down?Avalo Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Avalo Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Avalo Therapeutics is overvalued.
Is Avalo Therapeutics Stock a Buy?
-
Avalo Therapeutics share price is 4.95 while AVTX 8-day exponential moving average is 4.87, which is a Buy signal.
-
The stock price of AVTX is 4.95 while Avalo Therapeutics 20-day EMA is 4.75, which makes it a Buy.
-
Avalo Therapeutics 50-day exponential moving average is 4.84 while AVTX share price is 4.95, making it a Buy technically.
-
AVTX stock price is 4.95 and Avalo Therapeutics 200-day simple moving average is 13.58, creating a Sell signal.
Fundamental Analysis of Avalo Therapeutics
Is Avalo Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $2.91 per share, a decrease next quarter of $0.88 per share, a decrease this year of $17.29 per share, and an increase next year of $0.21 per share.
Technical Analysis of Avalo Therapeutics
Should I short Avalo Therapeutics stock?
-
AVTX Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Avalo Therapeutics is a Buy
-
Avalo Therapeutics Relative Strength Index (RSI) is 56.37, which suggest Avalo Therapeutics is overbought
-
The Bollinger Bands (25) for Avalo Therapeutics is (4.49 - 4.93), which suggest Avalo Therapeutics is a Sell
-
The Bollinger Bands (100) for Avalo Therapeutics is (4.12 - 7.12), which suggest Avalo Therapeutics is a Sell
* Avalo Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.